The impact of updated NICE guidelines on biologic treatment of ulcerative colitis: reflections on past practices, the changing present and implications for the future

被引：3

作者：

Samaan, Mark A. ^{[1
]}

Irving, Peter M. ^{[1
]}

机构：

[1] St Thomas Hosp, Guys & St Thomas NHS Fdn Trust, IBD Ctr, Dept Gastroenterol, North Wing, London, England

来源：

EXPERT OPINION ON BIOLOGICAL THERAPY | 2016年 / 16卷 / 08期

关键词：

Adalimumab; anti-TNF; golimumab; infliximab; NICE; vedolizumab; MAINTENANCE THERAPY; CLINICAL-RESPONSE; CROHNS-DISEASE; INFLIXIMAB; MODERATE; INDUCTION; TRIAL;

D O I：

10.1080/14712598.2016.1189529

中图分类号：

Q81 [生物工程学（生物技术）]; Q93 [微生物学];

学科分类号：

071005 ; 0836 ; 090102 ; 100705 ;

摘要：

引用

页码：975 / 977

页数：3